Institut Bordet - Retour à la page d'accueil
en
Donate to research

Marie Vercruyssen

Department : Hematology
 
Marie.Vercruyssen [at] bordet.be

Publications

Long-term follow-up of 2 patients treated with 90Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma.

Authors : Golstein SC, Muylle K, Vercruyssen M, Spilleboudt C, de Wind A, Bron D
Year : 2018
Journal : Eur J Haematol

Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation.

Authors : Cilla N, Vercruyssen M, Ameye L, Paesmans M, de Wind A, Heimann P, Meuleman N, Bron D
Year : 2018
Journal : Rev Med Brux

Monoclonal gammopathy of undetermined significance : when and why to look for them ?

Authors : Meuleman N, Vercruyssen M
Year : 2018
Journal : Rev Med Brux

More publications »

Follow us!

Youtube

Exclusive images of the new Jules Bordet Institute!

Watch the video and discover the major project for the new Jules Bordet Institute. Magnificent images of the construction work on the   80,000 m² dedicated exclusively to cancer are accompanied by explanations on how the project was conceived to combine excellence of patient care with optimal well-being for patients and care staff.